Published in Psychopharmacology (Berl) on February 05, 2008
Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev (2010) 3.46
Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings. Brain Res (2010) 1.41
Neurobiology of chronic mild stress: parallels to major depression. Neurosci Biobehav Rev (2012) 1.41
Dopaminergic activity in depressed smokers: a positron emission tomography study. Synapse (2009) 0.94
Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology (2008) 0.92
Striatal dopamine in bulimia nervosa: a PET imaging study. Int J Eat Disord (2012) 0.92
Dopamine receptor alterations in female rats with diet-induced decreased brain docosahexaenoic acid (DHA): interactions with reproductive status. Nutr Neurosci (2010) 0.86
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine. Neuropsychopharmacology (2016) 0.81
Molecular imaging in patients with mood disorders: a review of PET findings. Eur J Nucl Med Mol Imaging (2011) 0.81
N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence. CNS Neurol Disord Drug Targets (2013) 0.80
Striatal dopamine type 2 receptor availability in anorexia nervosa. Psychiatry Res (2015) 0.78
PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases. Quant Imaging Med Surg (2015) 0.78
Functional neuroimaging in geriatric depression. Psychiatr Clin North Am (2011) 0.77
Positron emission tomography molecular imaging in late-life depression. J Geriatr Psychiatry Neurol (2014) 0.76
Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain. Synapse (2016) 0.75
N-3 (omega-3) Fatty acids in postpartum depression: implications for prevention and treatment. Depress Res Treat (2010) 0.75
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol (1967) 22.39
Predictive reward signal of dopamine neurons. J Neurophysiol (1998) 15.02
Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab (2007) 11.79
Power and sample size calculations. A review and computer program. Control Clin Trials (1990) 9.58
Simplified reference tissue model for PET receptor studies. Neuroimage (1996) 8.28
The mesolimbic dopamine reward circuit in depression. Biol Psychiatry (2006) 7.62
The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry (1965) 5.09
The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry (2007) 4.51
Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage (1997) 4.13
Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab (2001) 3.31
Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab (2000) 2.95
Dopamine and the regulation of cognition and attention. Prog Neurobiol (2002) 2.72
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry (2001) 2.70
The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience (2000) 2.25
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry (1998) 2.03
Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol (2001) 1.65
The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol (2000) 1.60
Role of the dopaminergic system in depression. Biol Psychiatry (1992) 1.27
High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO. Biol Psychiatry (2005) 1.24
Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. Am J Psychiatry (2001) 1.22
Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study. Biol Psychiatry (2002) 1.18
Dopamine D2-like receptors and the antidepressant response. Biol Psychiatry (2006) 1.17
Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study. Am J Psychiatry (2006) 1.15
Assessment of spatial normalization of PET ligand images using ligand-specific templates. Neuroimage (1999) 1.12
Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride. J Cereb Blood Flow Metab (1993) 1.11
Clinical and psychometric correlates of dopamine D2 binding in depression. Psychol Med (1997) 1.08
Dopamine D2 receptors in depression measured with single photon emission computed tomography. Biol Psychiatry (1994) 1.06
Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biol Psychiatry (2001) 1.04
Striatal dopamine transporter density in major depression. Psychopharmacology (Berl) (1999) 1.03
Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride. Nucl Med Commun (2003) 1.01
Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging. Am J Psychiatry (2003) 0.99
Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry (2005) 0.97
Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography. Psychiatry Res (2006) 0.96
Does dopamine dysfunction drive depression? Acta Psychiatr Scand Suppl (2007) 0.95
Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study. J Affect Disord (2005) 0.95
Dopamine and depression--striatal dopamine D2 receptor SPECT before and after antidepressant therapy. Psychopharmacology (Berl) (1996) 0.95
A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey. Nucl Med Biol (2005) 0.90
Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression. J Affect Disord (2006) 0.87
Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia. Psychiatry Res (2005) 0.87
Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Res (1999) 0.83
Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography. Psychopharmacology (Berl) (1996) 0.81
Positron-labeled dopamine agonists for probing the high affinity states of dopamine subtype 2 receptors. Bioconjug Chem (2005) 0.81
Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls. Brain Res (1997) 0.80
Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride. Int J Neuropsychopharmacol (2004) 0.80
Caudate nucleus dopamine D(2) receptors in depressed suicide victims. Neuropsychobiology (2001) 0.80
Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride. J Affect Disord (2007) 0.79
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation (2006) 3.12
The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragment. J Biol Chem (2002) 2.44
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. Proc Natl Acad Sci U S A (2010) 2.32
Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol (2008) 2.24
Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol (2008) 2.19
EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging (2010) 2.09
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging (2008) 2.04
Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation (2008) 1.82
Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry (2005) 1.67
A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. Glycobiology (2009) 1.64
Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas. J Nucl Med (2010) 1.61
The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer. J Biol Chem (2005) 1.59
Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci (2005) 1.58
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects. Eur J Nucl Med Mol Imaging (2008) 1.55
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging (2009) 1.49
Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse (2007) 1.46
EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging (2009) 1.45
Brain glucose metabolism and temperament in relation to severe somatization. Psychiatry Clin Neurosci (2006) 1.40
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biol Psychiatry (2002) 1.37
Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication. Arch Neurol (2008) 1.31
Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain (2003) 1.29
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant. Biol Psychiatry (2004) 1.28
Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm Bowel Dis (2011) 1.27
Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol (2007) 1.27
Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: a voxel-based meta-analysis of functional magnetic resonance imaging studies. Eur Neuropsychopharmacol (2011) 1.21
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. Eur J Nucl Med Mol Imaging (2012) 1.21
The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics (2005) 1.19
Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol (2004) 1.17
Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells. Biochem J (2003) 1.15
Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl) (2005) 1.14
Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology (2010) 1.13
Alexithymia and somatization in general population. Psychosom Med (2008) 1.11
Altered dopamine D2 receptor binding in atypical facial pain. Pain (2003) 1.10
Increased brain fatty acid uptake in metabolic syndrome. Diabetes (2010) 1.10
C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse (2009) 1.10
Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biol Psychiatry (2007) 1.08
Personality traits and striatal dopamine synthesis capacity in healthy subjects. Am J Psychiatry (2003) 1.08
Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography. Cancer (2002) 1.07
Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage (2012) 1.07
Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution. Am J Physiol Gastrointest Liver Physiol (2013) 1.05
Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease. Mov Disord (2004) 1.03
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility. J Cereb Blood Flow Metab (2008) 1.02
Age is strongly associated with alexithymia in the general population. J Psychosom Res (2006) 1.02
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. J Clin Psychopharmacol (2002) 1.01
Anxiety and hostility are associated with reduced baroreflex sensitivity and increased beat-to-beat blood pressure variability. Psychosom Med (2003) 1.00
Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region. J Cereb Blood Flow Metab (2006) 1.00
Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: ([18F]SPA-RQ). Mol Imaging Biol (2004) 1.00
C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.00
Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation. J Alzheimers Dis (2008) 0.98
Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction. J Card Fail (2006) 0.98
Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry (2005) 0.97
The relationship of needs and quality of life in persons with schizophrenia living in the community. A Nordic multi-center study. Nord J Psychiatry (2003) 0.97
Structural characterization of alpha1,3-galactosyltransferase knockout pig heart and kidney glycolipids and their reactivity with human and baboon antibodies. Xenotransplantation (2010) 0.97
Psychiatric disorders as assessed with SCID in chronic pain patients: the anxiety disorders precede the onset of pain. Gen Hosp Psychiatry (2011) 0.96
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents. Neurobiol Aging (2012) 0.96
Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects. Neuroimage (2008) 0.96
Age-related loss of extrastriatal dopamine D(2) -like receptors in women. J Neurochem (2002) 0.96
The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans. Am J Physiol Endocrinol Metab (2008) 0.95
Minor change in the diagnostic threshold leads into major alteration in the prevalence estimate of depression. J Affect Disord (2009) 0.95
Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. Psychiatry Res (2002) 0.95
Alexithymia and health-related quality of life in a general population. Psychosomatics (2009) 0.94
Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain. Eur J Neurosci (2004) 0.94
Dopaminergic effects of caffeine in the human striatum and thalamus. Neuroreport (2004) 0.94
Two glycosylation alterations of mouse intestinal mucins due to infection caused by the parasite Nippostrongylus brasiliensis. Glycoconj J (2002) 0.94
Characterization of the outer membrane protein profile from disease-related Helicobacter pylori isolates by subcellular fractionation and nano-LC FT-ICR MS analysis. J Proteome Res (2006) 0.94
Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain (2002) 0.93
Lactotetraosylceramide, a novel glycosphingolipid receptor for Helicobacter pylori, present in human gastric epithelium. J Biol Chem (2002) 0.92
Sevoflurane and propofol increase 11C-flumazenil binding to gamma-aminobutyric acidA receptors in humans. Anesth Analg (2004) 0.92
Shape variability of the human striatum--Effects of age and gender. Neuroimage (2006) 0.92
Ketamine does not decrease striatal dopamine D2 receptor binding in man. Psychopharmacology (Berl) (2002) 0.92
Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation. Eur J Nucl Med Mol Imaging (2009) 0.92
Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG. J Nucl Med (2004) 0.91
A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia. Biol Psychiatry (2002) 0.91
Novel binding epitope for Helicobacter pylori found in neolacto carbohydrate chains: structure and cross-binding properties. J Biol Chem (2005) 0.90